Patent Issued for Methods, compositions and devices for treating cancer with illudofulvenes (USPTO 12023339).

This document is a patent for methods, compositions, and devices for treating cancer with illudofulvenes. The patent describes a method for using an acylfulvene compound to treat a cancerous tumor in a patient. The method involves determining the enhanced expression of a MYC biomarker and the attenuated expression of a TCR biomarker in the tumor. If these conditions are met, the patient is treated with an effective amount of the acylfulvene compound. The patent also includes additional claims and can be accessed for further information. [Extracted from the article]